Nutrastar International Quick Ratio (NUIN) starting from the third quarter 2015 to third quarter 2014, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Nutrastar International Inc.  (NUIN)

Nutrastar International's Quick Ratio

NUIN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Nutrastar International's Cash & cash equivalent grew by 0.57 % in the Q3 2015 sequentially, while Current Liabilities decreased, this led to improvement in Nutrastar International's Quick Ratio to 29.28, above Nutrastar International Inc. average Quick Ratio.

Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Quick Ratio than Nutrastar International in third quarter 2015. While Quick Ratio total ranking has improved so far during the Q3 2015 to 107, from total ranking in the second quarter 2015 at 133.

Explain Quick Ratio?
How much Cash & cash equivalents NUIN´s has?
What are NUIN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

NUIN Quick Ratio (Sep 30 2015)
Q3		 (Jun 30 2015)
Q2		 (Mar 31 2015)
Q1		 (Dec 31 2014)
Q4		 (Sep 30 2014)
Q3
Y / Y Current Liabilities Change 1.79 % 4.65 % 8.25 % -2.19 % -13.14 %
Y / Y Cash & cash equivalent Change 16.82 % 22.62 % 24.03 % 23.34 % 27.28 %
Quick Ratio MRQ 29.28 26.89 37.05 25.61 25.51
NUIN's Total Ranking # 107 # 133 # 133 # 129 # 129
Seq. Current Liabilities Change -7.62 % 48.35 % -30.12 % 6.3 % -5.03 %
Seq. Cash & cash equivalent Change 0.57 % 7.67 % 1.08 % 6.72 % 5.56 %



Quick Ratio third quarter 2015 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 26
Overall Market # 107


Quick Ratio Statistics
High Average Low
37.05 21.93 12.37
(Mar 31 2015)   (Dec 31 2011)




Financial Statements
Nutrastar International's Current Liabilities $ 5 Millions Visit NUIN's Balance sheet
Nutrastar International's Cash & cash equivalent $ 139 Millions Visit NUIN's Balance sheet
Source of NUIN's Sales Visit NUIN's Sales by Geography


Cumulative Nutrastar International's Quick Ratio

NUIN's Quick Ratio for the trailling 12 Months

NUIN Quick Ratio

 (Sep 30 2015)
12 Months		 (Jun 30 2015)
12 Months		 (Mar 31 2015)
12 Months		 (Dec 31 2014)
12 Months		 (Sep 30 2014)
12 Months
Y / Y Current Liabilities TTM Growth 2.61 % -1.75 % -5.8 % -10.53 % -10.38 %
Y / Y Cash & cash equivalent TTM Growth 21.55 % 24.21 % 25.5 % 27.39 % 30.54 %
Quick Ratio TTM 29.09 28.12 27.06 26.06 24.55
Total Ranking TTM # 2222 # 2330 # 2287 # 2408 # 2386
Seq. Current Liabilities TTM Growth 0.46 % 1.27 % 1.49 % -0.62 % -3.8 %
Seq. Cash & cash equivalent TTM Growth 3.9 % 5.23 % 5.38 % 5.48 % 6.18 %

Quick ratio ranking by company, industry and sector >> Back to NUIN Financial Strength Comparisons >> Go to Compare NUIN Quick Ratio to its Competitors

On the trailing twelve months basis NUIN Cash & cash equivalent increased by 16.82 % in Q3 2015 year on year, faster than Current Liabilities, this led to increase in in Nutrastar International's Quick Ratio to 29.09, above NUIN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Biotechnology & Pharmaceuticals industry 42 other companies have achieved higher Quick Ratio than Nutrastar International. While Quick Ratio overall ranking has improved so far to 2222, from total ranking during the twelve months ending second quarter 2015 at 2330.

Explain Quick Ratio?
How much Cash & cash equivalents NUIN´s has?
What are NUIN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry # 43
Healthcare Sector # 363
Within the Market # 2222


trailing twelve months Quick Ratio Statistics
High Average Low
29.09 21.35 15.48
(Sep 30 2015)   (Sep 30 2012)




Companies with similar Quick Ratio in the quarter ending Sep 30 2015, within Biotechnology & Pharmaceuticals Industry Quick RatioSep 30 2015 MRQ Cash & cash equivalentSep 30 2015 MRQ Current Liabilities
United Bancshares Inc  57.81 $ 20.000  Millions$ 0.346  Millions
Immunitybio inc   53.66 $ 358.616  Millions$ 6.683  Millions
Atara Biotherapeutics Inc   51.82 $ 334.265  Millions$ 6.450  Millions
Mosaic Immunoengineering Inc   51.09 $ 4.600  Millions$ 0.090  Millions
Iovance Biotherapeutics inc   45.78 $ 130.708  Millions$ 2.855  Millions
Adverum Biotechnologies Inc   41.39 $ 268.886  Millions$ 6.496  Millions
Regenxbio Inc   40.19 $ 213.349  Millions$ 5.308  Millions
La Jolla Pharmaceutical Company  31.11 $ 135.055  Millions$ 4.341  Millions
Nutrastar International Inc.  29.28 $ 138.512  Millions$ 4.731  Millions
Genocea Biosciences Inc   28.52 $ 97.611  Millions$ 3.422  Millions
Cidara Therapeutics Inc   26.76 $ 114.418  Millions$ 4.275  Millions
Protara Therapeutics Inc  22.27 $ 70.548  Millions$ 3.168  Millions
Bluebird Bio Inc   21.07 $ 707.464  Millions$ 33.577  Millions
Neurocrine Biosciences Inc   19.01 $ 376.845  Millions$ 19.822  Millions
Vivosim Labs Inc   13.93 $ 76.863  Millions$ 5.518  Millions
Momenta Pharmaceuticals inc   12.43 $ 374.869  Millions$ 30.159  Millions
Atyr Pharma Inc   12.40 $ 108.803  Millions$ 8.776  Millions
Compugen Ltd  11.94 $ 81.847  Millions$ 6.854  Millions
Novavax inc   11.67 $ 290.186  Millions$ 24.873  Millions
Aceragen Inc   11.57 $ 66.024  Millions$ 5.706  Millions
Spark Therapeutics Inc   11.40 $ 212.159  Millions$ 18.616  Millions
Cardiff Oncology Inc   10.64 $ 74.150  Millions$ 6.969  Millions
Polarityte Inc   10.11 $ 17.053  Millions$ 1.686  Millions
Curis Inc   10.05 $ 93.470  Millions$ 9.303  Millions
Sangamo Therapeutics Inc   9.91 $ 219.329  Millions$ 22.128  Millions
Acceleron Pharma inc  9.00 $ 115.897  Millions$ 12.872  Millions
Voyager Therapeutics Inc   8.63 $ 201.731  Millions$ 23.366  Millions
Vaxart Inc   8.54 $ 57.200  Millions$ 6.700  Millions
Aerie Pharmaceuticals Inc   8.39 $ 155.238  Millions$ 18.512  Millions
Fresh Tracks Therapeutics Inc   7.65 $ 41.851  Millions$ 5.474  Millions

Date modified: 2026-09-26T07:15:13+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.